Novavax
NVAX
#5661
Rank
S$1.46 B
Marketcap
S$9.03
Share price
-3.71%
Change (1 day)
-59.04%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of March 2025 : S$0.29 Billion

According to Novavax's latest financial reports the company's total debt is S$0.29 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$0.31 B3.52%
2023-12-31S$0.30 B-58.95%
2022-12-31S$0.73 B20.09%
2021-12-31S$0.61 B-0.86%
2020-12-31S$0.61 B42.67%
2019-12-31S$0.43 B-0.48%
2018-12-31S$0.43 B2.6%
2017-12-31S$0.42 B-7.17%
2016-12-31S$0.45 B81841.15%
2015-12-31S$0.55 M-57.63%
2014-12-31S$1.31 M-44.67%
2013-12-31S$2.38 M61.73%
2012-12-31S$1.47 M255.58%
2011-12-31S$0.41 M-19.57%
2010-12-31S$0.51 M-24.48%
2009-12-31S$0.68 M-97.92%
2008-12-31S$32.76 M0.08%
2007-12-31S$32.73 M-7.94%
2006-12-31S$35.55 M-30.05%
2005-12-31S$50.83 M-16.16%
2004-12-31S$60.62 M-15.37%
2003-12-31S$71.63 M-0.28%
2002-12-31S$71.84 M13.02%
2001-12-31S$63.56 M83.38%
2000-12-31S$34.66 M20718.62%
1999-12-31S$0.16 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
S$0.11 B-59.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$1.73 B 487.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.85 B 191.13%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$1.02 B 247.67%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$40.29 B 13,585.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$78.91 B 26,704.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$40.26 B 13,575.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
S$1.93 M-99.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$30.66 B 10,315.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
S$4.41 M-98.50%๐Ÿ‡บ๐Ÿ‡ธ USA